Baron Funds, an investment management company, released its “Baron Health Care Fund” third quarter 2024 investor letter. A copy of the letter can be downloaded here. The fund appreciated 5.81%% (Institutional Shares) in the quarter compared to a 6.74% gain for the Russell 3000 Health Care Index (benchmark) and a 6.23% gain for the Russell 3000 Index (the Index). Since inception, the fund appreciated 13.02% on an annualized basis compared to an 11.47% gain for the benchmark and a 14.03% gain for the index. In addition, please check the fund’s top five holdings to know its best picks in 2024.
Baron Health Care Fund highlighted stocks like IRhythm Technologies, Inc. (NASDAQ:IRTC), in the third quarter 2024 investor letter. IRhythm Technologies, Inc. (NASDAQ:IRTC) is a digital healthcare company that designs, and develops device-based technology to provide ambulatory cardiac monitoring services. The one-month return of IRhythm Technologies, Inc. (NASDAQ:IRTC) was 15.52% and its shares lost 13.02% of their value over the last 52 weeks. On October 31, 2024, IRhythm Technologies, Inc. (NASDAQ:IRTC) stock closed at $72.44 per share with a market capitalization of $2.37 billion.
Baron Health Care Fund stated the following regarding IRhythm Technologies, Inc. (NASDAQ:IRTC) in its Q3 2024 investor letter:
“IRhythm Technologies, Inc. (NASDAQ:IRTC) sells a small wearable patch (the Zio) for the detection of heart arrhythmia. Shares fell during the quarter. The company has been the subject of multiple investigations by the DOJ and the FDA. The FDA recently conducted a site inspection during which it identified issues across the product portfolio. In light of the uncertainty around these ongoing investigations, we took a tax loss while we reconsider the investment thesis.”
A patient being monitored with a portable ECG device, showing the effectiveness of the company’s products.vascular
IRhythm Technologies, Inc. (NASDAQ:IRTC) is not on our list of 31 Most Popular Stocks Among Hedge Funds. As per our database, 18 hedge fund portfolios held IRhythm Technologies, Inc. (NASDAQ:IRTC) at the end of the second quarter which was 31 in the previous quarter. IRhythm Technologies, Inc. (NASDAQ:IRTC) generated revenue of $148 million in the second quarter 2024, representing 19.3% year-over-year increase. While we acknowledge the potential of IRhythm Technologies, Inc. (NASDAQ:IRTC) as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns, and doing so within a shorter timeframe. If you are looking for an AI stock that is as promising as NVIDIA but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock.
In another article, we discussed IRhythm Technologies, Inc. (NASDAQ:IRTC) and shared Artisan Mid Cap Fund’s views on the company. Baron Health Care Fund initiated a position in IRhythm Technologies, Inc. (NASDAQ:IRTC) during Q1 2024. In addition, please check out our hedge fund investor letters Q3 2024 page for more investor letters from hedge funds and other leading investors.
READ NEXT: Michael Burry Is Selling These Stocks and A New Dawn Is Coming to US Stocks.
Disclosure: None. This article is originally published at Insider Monkey.